Twist Bioscience stock edges lower to $90.82 after DNA supply chain podcast, Twist Bioscience posts

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience slides 0.56% today

Highlights

TWST shows robust medium- and long-term bullish momentum, trading well above its 50- and 200-day moving averages.
Momentum indicators flash mostly bullish signals, though overbought readings and a slight loss of upward drive suggest short-term consolidation risk.
Key resistance stands at $94.10 with support at $82.67; next week’s expected range is $83.50 to $99.90 amid elevated volatility.

The episode is titled 'Inside the DNA Supply Chain Powering Modern Drug Discovery.' A link to the episode was provided in the announcement.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish long-term stance as price nears key resistance levels

TWST is currently trading at $90.82, just below the SMA-20 ($91.83), indicating slight short-term resistance, but above both the SMA-50 ($82.67) and SMA-200 ($52.28), which confirms firm medium- and long-term bullish momentum. The Ichimoku Kijun on D1 stands at $94.10, marking immediate resistance. Near-term support lies at the SMA-50 ($82.67), with key support at the SMA-100 ($67.46). Immediate resistance is at the Ichimoku Kijun ($94.10), followed by key resistance at the SMA-20 ($91.83).

Overbought momentum fades as price consolidates near volatility peak

Momentum indicators on D1 show ongoing buyer control, with MACD and ADX both issuing Buy signals, though ADX's value suggests a moderate trend strength. RSI is neutral-bullish near 53, while Stoch RSI on D1 and BBP both indicate overbought conditions and sustained buyer dominance, but CCI trending below zero flags some loss of upside drive. Awesome Oscillator remains neutral, offering no added confirmation. TWST has risen $0.55 (0.51%) since last week's close at $90.27, with the price now in the upper part of this week's wide volatility band (15.11%). Recent action points to price consolidation after rebounding sharply from the weekly low, with some loss of momentum as the price eases back from the high.

Upside favored as volatility and resistance cap short-term outlook

Looking to the coming week, the expected price range is $83.50 to $99.90, keeping the outlook within ±10% of the current price and reflecting the asset's recent volatility. Bullish signals dominate on W1: RSI, ADX, MACD, and MA-50 all issue Buy recommendations, placing the probability of further gains at the maximum ("very high probability, more than 80%"), while declines are much less likely. The baseline scenario sees the price fluctuating in a broad sideways band below resistance, while a bullish scenario would be triggered by a move above $94.10, opening a path toward the upper end of the range. A bearish turn below $82.67 would expose the asset to deeper short-term retracements, though broader trends remain positive. The forecast range is positioned well above the 52-week low ($23.30) and remains within reach of the 52-week high ($105.41), underlining TWST’s strong recovery and elevated volatility.

In a recent review, Twist Bioscience was characterized by analysts as having strong medium- and long-term bullish momentum, supported by sustained buyer interest but tempered by short-term overbought signals. The current analysis builds on this perspective by highlighting the need to monitor the next key resistance, as a breakout could shift the prevailing scenario and present fresh trading opportunities.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.